Cargando…
Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis
B cell depletion therapy using rituximab has been shown to be effective in achieving remission in patients with HCV-mixed cryoglobulinemic (MC) vasculitis. Previously, we have demonstrated abnormalities in peripheral immune cells involving neutrophils, chemotaxis, and innate immune activation among...
Autores principales: | Comstock, Emily, Kim, Cheol-Woo, Murphy, Alison, Emmanuel, Benjamin, Zhang, Xi, Sneller, Michael, Poonia, Bhawna, Kottilil, Shyamasundaran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724854/ https://www.ncbi.nlm.nih.gov/pubmed/29228031 http://dx.doi.org/10.1371/journal.pone.0188314 |
Ejemplares similares
-
Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
por: Ghosh, Alip, et al.
Publicado: (2020) -
Hepatitis C-Associated Mixed Cryoglobulinemic Vasculitis Induces Differential Gene Expression in Peripheral Mononuclear Cells
por: Sidharthan, Sreetha, et al.
Publicado: (2014) -
Immunopathogenic Background of Pars Planitis
por: Przeździecka-Dołyk, Joanna, et al.
Publicado: (2015) -
Peripheral PD-1(+) T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
por: Romani, Sara, et al.
Publicado: (2019) -
An immunopathogenic perspective of interleukin-1 signaling
por: Lin, Xinwen, et al.
Publicado: (2020)